|
Index of reports
> Cases resulting in life threatening events (48)
> Cases with Nausea (8)
Below is the selection of adverse event reports related to Singulair (Montelukast) that includes cases resulting in life threatening events where reactions include nausea.
Adverse event in 6 year old female receiving Singulair (Montelukast)
Reported by a individual with unspecified qualification from United States on 2007-10-17
Patient: 6 year old female, weighing 22.2 kg (48.9 pounds)
Adverse reactions / side effects: Nausea, Heart Rate Increased, Feeling Abnormal, Erythema, Pallor, Tremor
Adverse event resulted in: life threatening event
Suspect drug(s):
Singulair (Montelukast)
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-05-15
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Syncope, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-05-11
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 47 year old female receiving Singulair (Montelukast)
Reported by a physician from United States on 2007-04-04
Patient: 47 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Nausea, Hypoaesthesia, Cerebrovascular Accident, Throat Tightness, Abdominal Pain Upper, Abdominal Discomfort, Haematochezia, Diarrhoea, Bipolar Disorder, Small Intestinal Perforation, Drug Administration Error, Adverse Event
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2003-01-01
End date: 2005-01-01
Singulair
Administration route: Oral
Start date: 2004-10-21
Singulair
Administration route: Oral
Singulair
Administration route: Oral
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2003-01-01
End date: 2005-01-01
Singulair
Administration route: Oral
Start date: 2004-10-21
Singulair
Administration route: Oral
Other drugs received by patient: Valium
Adverse event in 47 year old female receiving Singulair (Montelukast)
Reported by a physician from United States on 2007-03-06
Patient: 47 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Nausea, Hypoaesthesia, Cerebrovascular Accident, Throat Tightness, Abdominal Pain Upper, Abdominal Discomfort, Haematochezia, Diarrhoea, Bipolar Disorder, Small Intestinal Perforation, Drug Administration Error, Adverse Event
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2003-01-01
End date: 2005-01-01
Singulair
Administration route: Oral
Start date: 2004-10-21
Singulair
Administration route: Oral
Singulair
Administration route: Oral
Indication: Chronic Obstructive Pulmonary Disease
Start date: 2003-01-01
End date: 2005-01-01
Singulair
Administration route: Oral
Start date: 2004-10-21
Singulair
Administration route: Oral
Other drugs received by patient: Valium
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-20
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-19
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Myalgia, Face Oedema, Fatigue, DRY Mouth, Chest Pain, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-09
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Petechiae, Headache, Somnolence, Generalised Oedema, Myalgia, Fatigue, Chest Pain, DRY Mouth, Abdominal Distension, Dizziness, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Aspirin; Levothyroxine Sodium; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
|
